Trigger Finger Trial
A Randomized Control Trial to Evaluate Incision Versus Excision of A1 Pulley for Trigger Finger
1 other identifier
interventional
80
1 country
6
Brief Summary
Trigger finger is a common condition of the hand caused by the thickening of the A1 pulley or flexor tendon that alters the way in which the flexor tendon glides within the tendon sheath. The purpose of this study is to evaluate the efficacy of excision versus incision of the A1 pulley for the trigger finger. Researchers hypothesize that excision of the A1 pulley would result in lower trigger finger recurrence rates, better pain relief, reduced soreness \& stiffness as well as higher final Patient-Reported Outcomes Measurement (PROMs). This will be investigated via a randomized controlled study involving patients randomized in either of the aforementioned surgical treatment groups, which are both standards of care, at the Musculoskeletal Institute or at the Emory University Orthopaedic and Spine Hospital. Patients will then follow up in the clinic at 2 weeks, 6 weeks, 3 months, 6 months, and 1 year to assess their outcomes measures stated in the protocol document. All work related to this project will take place at the Emory Sports Medicine Complex, Emory Executive Park, Emory Musculoskeletal Institute, and the Emory University Orthopaedic and Spine Hospital. Patients will not be compensated for participating in this study. Patients who are undergoing trigger finger surgery will be identified by their Orthopaedic surgeon who is a member of the study team. The surgeon will briefly discuss participation with the patient and make clear study expectations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2022
CompletedFirst Posted
Study publicly available on registry
February 22, 2022
CompletedStudy Start
First participant enrolled
January 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2025
CompletedJanuary 22, 2026
January 1, 2026
12 months
February 1, 2022
January 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in the pain score
Participants will be asked to complete questionnaires to evaluate their pain at each follow-up visit. The Visual Analog Scale will be the subjective measurement to evaluate changes in pain scores, with values ranging from 0 (no pain) to 10 (very severe pain). A higher score indicates worse pain.
Baseline and 6 weeks
Other Outcomes (4)
Change in the range of motion (ROM)
Baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
Change in patients' reported Working status
Baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
Change in the pain score
Baseline, 2 weeks, 3 months, 6 months, and 1 year
- +1 more other outcomes
Study Arms (2)
excision of the A1 pulley
EXPERIMENTALincision of the A1 pulley in the standard fashion
ACTIVE COMPARATORInterventions
Participants will undergo incision of the A1 pulley in the standard fashion. Wounds will then be irrigated and closed in the standard fashion.
Participants will undergo excision of the A1 pulley. Wounds will then be irrigated and closed in the standard fashion.
Eligibility Criteria
You may qualify if:
- Age 18 or older
- All patients undergoing surgery for trigger finger syndrome
- Patients willing and able to provide informed consent
You may not qualify if:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (6)
Emory Orthopedic and Spine Hospital
Atlanta, Georgia, 30084, United States
12 Executive Park Drive
Atlanta, Georgia, 30329, United States
Emory Musculoskeletal Institute
Atlanta, Georgia, 30329, United States
Emory Orthopaedics and Spine Center
Atlanta, Georgia, 30329, United States
Emory at Dunwoody
Atlanta, Georgia, 30338, United States
Emory Saint Joseph's Hospital
Atlanta, Georgia, 30342, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Wagner, MD, MS
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 1, 2022
First Posted
February 22, 2022
Study Start
January 30, 2023
Primary Completion
January 12, 2024
Study Completion
November 20, 2025
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share